Halma plc (LON:HLMA - Get Free Report) insider Marc Ronchetti sold 36,245 shares of Halma stock in a transaction dated Friday, June 27th. The shares were sold at an average price of GBX 3,248 ($44.56), for a total value of £1,177,237.60 ($1,615,087.94).
Marc Ronchetti also recently made the following trade(s):
- On Thursday, June 26th, Marc Ronchetti sold 5,889 shares of Halma stock. The stock was sold at an average price of GBX 3,202 ($43.93), for a total transaction of £188,565.78 ($258,699.11).
Halma Stock Down 0.1%
Shares of HLMA opened at GBX 3,212 ($44.07) on Monday. Halma plc has a 52 week low of GBX 2,316 ($31.77) and a 52 week high of GBX 3,342 ($45.85). The stock has a market capitalization of £12.10 billion, a price-to-earnings ratio of 44.93, a PEG ratio of 2.93 and a beta of 0.53. The company has a debt-to-equity ratio of 45.83, a quick ratio of 1.51 and a current ratio of 2.45. The stock has a fifty day moving average of GBX 2,944.33 and a 200-day moving average of GBX 2,812.89.
Halma (LON:HLMA - Get Free Report) last issued its earnings results on Thursday, June 12th. The company reported GBX 94.23 ($1.29) earnings per share (EPS) for the quarter. Halma had a return on equity of 15.87% and a net margin of 13.21%. As a group, sell-side analysts anticipate that Halma plc will post 90.5626134 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Separately, Shore Capital reiterated a "hold" rating on shares of Halma in a research report on Thursday, March 13th.
Get Our Latest Stock Report on HLMA
Halma Company Profile
(
Get Free Report)
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:
- Safety - Protecting people's safety and the environment as populations grow, and enhancing worker safety.
- Environment - Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
- Health - Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.
Halma employs over 8,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Halma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Halma wasn't on the list.
While Halma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.